Ocean Biomedical (OCEA) Stock Price, News & Analysis

Company Overview

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Key Stats

• Today's Range: $0.55 to $0.67
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 58,009 shs
• Average Volume: 87.92 million shs
• Market Capitalization: $4.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ocean Biomedical Stock Analysis - MarketRank™

Ocean Biomedical scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ocean Biomedical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ocean Biomedical is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ocean Biomedical is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

15.27% of the float of Ocean Biomedical has been sold short.

Short Interest Ratio / Days to Cover

Ocean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ocean Biomedical has recently increased by 211.52%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ocean Biomedical does not currently pay a dividend.

Dividend Growth

Ocean Biomedical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

15.27% of the float of Ocean Biomedical has been sold short.

Short Interest Ratio / Days to Cover

Ocean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ocean Biomedical has recently increased by 211.52%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

Search Interest

26 people have searched for OCEA on MarketBeat in the last 30 days. This is an increase of 420% compared to the previous 30 days.

MarketBeat Follows

5 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.

Percentage Held by Insiders

73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 24.55% of the stock of Ocean Biomedical is held by institutions.

OCEA Stock Analysis - Frequently Asked Questions

How were Ocean Biomedical's earnings last quarter?

Ocean Biomedical, Inc. (NASDAQ:OCEA) released its quarterly earnings data on Monday, January, 13th. The company reported ($0.20) EPS for the quarter.

When did Ocean Biomedical IPO?

Ocean Biomedical (OCEA) raised $22 million in an initial public offering (IPO) on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading acted as the underwriters for the IPO.

Who are Ocean Biomedical's major shareholders?

Ocean Biomedical's top institutional investors include Citadel Advisors LLC.

What other stocks do shareholders of Ocean Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocean Biomedical investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Alphabet (GOOG), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

• Last Earnings: 1/13/2025
• Today: 2/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:OCEA
• CUSIP: N/A
• CIK: 1836612
• Web: N/A
• Phone: 646-908-2658
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-114,470,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -931.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.62) per share
• Price / Book: -0.05

Miscellaneous

• Outstanding Shares: 34,870,000
• Free Float: 9,240,000
• Market Cap: $4.39 million
• Optionable: Optionable
• Beta: 1.31